Pediatric Allogeneic Bone Marrow Transplant for Leukemia (ALL, AML, CML) at Sheba Hospital- JCI accredited and Top Ten Hospitals 2026 by Newsweek
このパッケージに含まれるもの
医療処置
- 全血球計算検査
- 生化学的血液検査
- 血液内科相談
- 血液検査
- 骨髄生検
- オンコヘマトロジー相談
- 白血病の包括的検査
- 骨髄細胞遺伝学的検査
- 骨髄移植術
- 栄養士による1日3食
- 24時間看護サービス
- 心電図(ECG)
- 血液検査
- 胸部X線
- HIV抗体検査
- B型肝炎コア抗体検査
- 抗HCV抗体検査
- 心エコー図検査
- 全血球計算(CBC)
- 生化学血液検査
- PET/CT
- 免疫専門医への相談
- 循環器科医への相談
- 小児血液専門医との相談
- 小児科医との相談
- 腫瘍血液専門医との診察
- 頭部MRI
- 生検
- 腫瘍マーカーおよび蛋白分画を含む全血球算定
期間
- 30 日 病院で
宿泊
入院
交通
空港-クリニック-空港間の送迎
追加情報
Pediatric Allogeneic Bone Marrow Transplant for Leukemia (ALL, AML, CML)
Sheba Medical Center – Personalized, Advanced Care for Children
JCI-Accredited | Ranked Among the World’s Top 10 Hospitals by Newsweek 2026
At Sheba Medical Center, we understand that a diagnosis of leukemia in a child changes everything for a family. Our Pediatric Bone Marrow Transplant (BMT) program is designed to provide not only world-class medical care, but also reassurance, compassion, and hope at every step.
As one of the world’s leading pediatric transplant centers, Sheba combines decades of experience with cutting-edge therapies to perform allogeneic bone marrow transplantation, a transplant using healthy stem cells from a donor, for children with acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML).
For children with high-risk, relapsed, or treatment-resistant leukemia, allogeneic transplantation often offers the strongest chance for long-term cure.
When is an Allogeneic Bone Marrow Transplant Needed?
For many children, leukemia can be successfully treated with chemotherapy. However, in certain situations - such as relapse, resistance to treatment, or aggressive disease, an allogeneic bone marrow transplant becomes the most effective treatment option.
In an allogeneic transplant, the child receives healthy stem cells from a donor. These cells rebuild the bone marrow and create a new immune system capable of recognizing and fighting leukemia cells.
This approach is commonly recommended for:
High-risk ALL or AML
Relapsed leukemia
Leukemia that does not respond fully to standard therapy
Selected cases of CML and other complex hematologic conditions
A Personalized Approach to Every Child
No two children are the same, and neither are their treatments.
At Sheba, every child is evaluated by a multidisciplinary team of pediatric hemato-oncology and transplant specialists who carefully determine the optimal treatment strategy, timing, conditioning regimen, and donor source.
Whenever possible, a matched sibling donor is preferred. If a sibling match is not available, Sheba actively secures the best possible alternative donor using advanced matching technologies and international donor registries.
Donor options include:
Matched unrelated donors through global donor programs
Haploidentical (partial-match) family donors, often parents
Cord blood transplantation
With advanced HLA and molecular laboratories on-site, Sheba performs highly precise donor matching to maximize safety and transplant success.
Advanced Transplant Techniques
Sheba Medical Center is recognized internationally for utilizing some of the most advanced transplant technologies available today, including:
T-cell depletion and CD34+ selection to reduce complications and improve transplant outcomes
Integration of CAR-T cell therapy prior to transplant in selected high-risk leukemia cases
Access to innovative clinical trials and advanced cellular therapies
Personalized conditioning and supportive care protocols tailored for children
These advanced approaches allow Sheba to safely treat even highly complex or previously difficult-to-treat cases.
World-Class Outcomes
Sheba’s Pediatric BMT program consistently achieves outcomes aligned with leading international transplant centers:
ALL & AML (first or second remission): approximately 75–85% success rates
Improved outcomes in relapsed leukemia through integration of advanced cellular therapies
Strong long-term survival and quality of life for pediatric patients
Our continuous research, innovation, and clinical expertise help provide children with the best possible opportunity for cure and recovery.
Precision, Safety, and Specialized Pediatric Care
Children undergoing transplantation are cared for in dedicated pediatric transplant units designed specifically for safety, comfort, and healing.
Care includes:
Highly protected, child-friendly environments
Advanced infection prevention systems
Continuous monitoring by experienced pediatric transplant specialists
Comprehensive supportive care throughout every phase of treatment and recovery
Every aspect of care is adapted to support children physically, emotionally, and developmentally.
Care Beyond Treatment
A bone marrow transplant is more than a medical procedure - it is a journey for the entire family.
At Sheba, families receive continuous guidance, emotional support, and clear communication throughout every stage of care. Our multidisciplinary team includes physicians, nurses, psychologists, social workers, rehabilitation specialists, and international patient coordinators.
From diagnosis through long-term follow-up, we remain closely involved, helping each child not only overcome leukemia, but return to a healthy and fulfilling life.
Why Families Choose Sheba
Leading pediatric transplant center with global recognition
Expertise in complex and high-risk leukemia cases
Advanced allogeneic transplantation capabilities
Ability to secure suitable donors—even without a family match
Integration of CAR-T and advanced cellular therapies
Multidisciplinary, patient-centered pediatric care
Dedicated international patient services for a smooth experience
A Message of Hope
At Sheba Medical Center, we believe every child deserves access to the most advanced treatments available, delivered with compassion, precision, and unwavering commitment.
For children facing leukemia, allogeneic bone marrow transplantation at Sheba is more than a treatment option - it is a pathway toward healing, recovery, and a brighter future.
24時間年中無休Bookimedサポート
- 専任医療コーディネーター
- 医療旅行手配 — 特別パートナー価格での航空券・ホテル予約
- 医療旅行中の患者擁護
プログラム料金
まで有効な特別価格 July 29, 2026
このパッケージに含まれないもの
医師
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
調子はいかがですか?
クリニックについて
シェバ医療センターはイスラエルおよび世界有数の病院の一つです。 ニューズウィーク・インターナショナル誌は、Sheba Hospitalを2020年の世界トップ10病院にランク付けしました。同病院は1,990の専門分野をカバーしており、毎年世界中から1,500,000人を超える患者がシェバ病院を受診しています。
支払い・特典
当社サービスへのお支払いはありません
クリニックで直接またはその公式銀行口座にお支払いいただきます。
一部のクリニックでは保証金が必要な場合があります。
分割払いオプションでお支払いを分散してください。
Bookimedにお友達を紹介して報酬を獲得してください。